Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial - MD Linx

Submitted by Anonymous (not verified) on Mon, 06/10/2019 - 11:05

Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial  MD LinxJAMA — Daly EJ, et al. | June 10, 2019. Advertisement. Through a phase 3, multicenter, double-blind, randomized withdrawal study of 297 adult patients with ...